Biora Therapeutics Inc

BIOR11 Dec 2024
Healthcare
$0.71
-0.59 (-58.54%)
Lowest Today
$0.53
Highest Today
$0.79
Today’s Open
$0.71
Prev. Close
$1.35
52 Week High
$19.9
52 Week Low
$0.53
To Invest in Biora Therapeutics Inc

Biora Therapeutics Inc

Healthcare
BIOR11 Dec 2024
-0.59 (-58.54%)
1M
3M
6M
1Y
5Y
Low
$0.53
Day’s Range
High
$0.79
0.53
52 Week Low
$0.53
52-Week Range
52 Week High
$19.9
0.53
1 Day
-
1 Week
-61.82%
1 month return
-80.28%
3 month return
-16.62%
6 month return
-22.74%
1 Year return
-62.09%
3 Years return
-99.14%
5 Years return
-
10 Years return
-
Institutional Holdings
Athyrium Capital Management LP
24.17
Vanguard Group Inc
1.54
Vanguard Total Stock Mkt Idx Inv
0.82
Vanguard Institutional Extnd Mkt Idx Tr
0.72
Geode Capital Management, LLC
0.42
Morgan Stanley - Brokerage Accounts
0.27
Fidelity Extended Market Index
0.18

Market Status

Fundamentals
Market Cap
6.11 mln
PB Ratio
0
PE Ratio
3.75
Enterprise Value
42.65 mln
Total Assets
31.22 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
Organisation
Biora Therapeutics Inc
Employees
58
Industry
Biotechnology
CEO
Mr. Aditya P. Mohanty M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities